Sort   by:  
 Page size 
A substantial part of cutaneous malignant melanomas develops from benign nevi. However, the precise molecular events driving the transformation from benign to malignant melanoma are not well understood. We used laser microdissection and mass spectrometry to analyze the proteomes of melanoma subtypes...
ORGANISM(S): Homo sapiens (Human) 
2024-01-28 | PXD044107 | Pride
A number of melanoma specific genes were identified to differentiate clinical relevant tissue samples containing benign from malignant melanocytes. Experiment Overall Design: 7 normal skin, 18 nevi and 45 melanoma samples
ORGANISM(S): Homo sapiens 
Despite malignant cutaneous melanoma is relatively rare compared to other skin cancers, it is still responsible for 80% of all skin cancer-related deaths. To identify molecular signatures of melanoma progression, excisional biopsies from 18 common melanocytic nevi (CMN), 8 primary radial growth phas...
ORGANISM(S): Homo sapiens 
Progressive immune activation and negative immunoregulation from common melanocytic nevi to dysplastic nevi to melanoma
Molecular Profiling of Spitz Nevi (SN) in Relation to Nevocellular Nevi (NCN)
CD4+ T cells Reject Benign Melanocytic Nevi
Nevi are common benign melanocytic neoplasms that can be found on any skin location and share many of the genomic hallmarks of melanoma. In our recent report involving whole-exome sequencing of acquired nevi (Stark et al., 2018), ultra-violet radiation (UVR) related somatic mutation signatures (“sig...
Deconvoluted methylation profiles discriminate between closely related melanocytic nevi
Cellular and molecular differences between DNs and CMNs are not completely understood. Using cDNA microarray, quantitative RT-PCR, and immunohistochemistry, we molecularly characterized DNs and analyzed the difference between DNs and CMNs. total RNA was extratced from sliced full thickness tissue s...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size